223 related articles for article (PubMed ID: 37446253)
1. Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice.
Martel A; Mograbi B; Romeo B; Gastaud L; Lalvee S; Zahaf K; Fayada J; Nahon-Esteve S; Bonnetaud C; Salah M; Tanga V; Baillif S; Bertolotto C; Lassalle S; Hofman P
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446253
[TBL] [Abstract][Full Text] [Related]
2. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
[TBL] [Abstract][Full Text] [Related]
3. Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.
Bidard FC; Madic J; Mariani P; Piperno-Neumann S; Rampanou A; Servois V; Cassoux N; Desjardins L; Milder M; Vaucher I; Pierga JY; Lebofsky R; Stern MH; Lantz O
Int J Cancer; 2014 Mar; 134(5):1207-13. PubMed ID: 23934701
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells in uveal melanoma.
Torres V; Triozzi P; Eng C; Tubbs R; Schoenfiled L; Crabb JW; Saunthararajah Y; Singh AD
Future Oncol; 2011 Jan; 7(1):101-9. PubMed ID: 21174541
[TBL] [Abstract][Full Text] [Related]
5. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
[TBL] [Abstract][Full Text] [Related]
8. Characterization of circulating tumor cells in breast cancer patients by spiral microfluidics.
Yin J; Wang Z; Li G; Lin F; Shao K; Cao B; Hou Y
Cell Biol Toxicol; 2019 Feb; 35(1):59-66. PubMed ID: 30430365
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.
Sawada T; Araki J; Yamashita T; Masubuchi M; Chiyoda T; Yunokawa M; Hoshi K; Tao S; Yamamura S; Yatsushiro S; Abe K; Kataoka M; Shimoyama T; Maeda Y; Kuroi K; Tamura K; Sawazumi T; Minami H; Suda Y; Koizumi F
EBioMedicine; 2016 Sep; 11():173-182. PubMed ID: 27495793
[TBL] [Abstract][Full Text] [Related]
11. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
Khoja L; Backen A; Sloane R; Menasce L; Ryder D; Krebs M; Board R; Clack G; Hughes A; Blackhall F; Valle JW; Dive C
Br J Cancer; 2012 Jan; 106(3):508-16. PubMed ID: 22187035
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
[TBL] [Abstract][Full Text] [Related]
13. Improving the CellSearch® system.
Swennenhuis JF; van Dalum G; Zeune LL; Terstappen LW
Expert Rev Mol Diagn; 2016 Dec; 16(12):1291-1305. PubMed ID: 27797592
[TBL] [Abstract][Full Text] [Related]
14. Fast and Label-Free Isolation of Circulating Tumor Cells from Blood: From a Research Microfluidic Platform to an Automated Fluidic Instrument, VTX-1 Liquid Biopsy System.
Lemaire CA; Liu SZ; Wilkerson CL; Ramani VC; Barzanian NA; Huang KW; Che J; Chiu MW; Vuppalapaty M; Dimmick AM; Carlo DD; Kochersperger ML; Crouse SC; Jeffrey SS; Englert RF; Hengstler S; Renier C; Sollier-Christen E
SLAS Technol; 2018 Feb; 23(1):16-29. PubMed ID: 29355087
[TBL] [Abstract][Full Text] [Related]
15. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
Ilie M; Szafer-Glusman E; Hofman V; Long-Mira E; Suttmann R; Darbonne W; Butori C; Lalvée S; Fayada J; Selva E; Yu W; Marquette CH; Shames DS; Punnoose E; Hofman P
Oncotarget; 2017 Apr; 8(16):26112-26121. PubMed ID: 28212540
[TBL] [Abstract][Full Text] [Related]
16. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells.
Sheng Y; Wang T; Li H; Zhang Z; Chen J; He C; Li Y; Lv Y; Zhang J; Xu C; Wang Z; Huang C; Wang L
Oncotarget; 2017 Jan; 8(5):8801-8806. PubMed ID: 28187533
[TBL] [Abstract][Full Text] [Related]
17. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
18. Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma.
De Giorgi V; Pinzani P; Salvianti F; Panelos J; Paglierani M; Janowska A; Grazzini M; Wechsler J; Orlando C; Santucci M; Lotti T; Pazzagli M; Massi D
J Invest Dermatol; 2010 Oct; 130(10):2440-7. PubMed ID: 20535130
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Thiel E; Foerster MH; Keilholz U
Oncology; 2011; 80(1-2):57-62. PubMed ID: 21625180
[TBL] [Abstract][Full Text] [Related]
20. Uveal melanoma dormancy: an acceptable clinical endpoint?
Blanco PL; Lim LA; Miyamoto C; Burnier MN
Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
